FILE:ALXN/ALXN-8K-20080204172903.txt.gz
EVENTS:	Other Events
TEXT:
ITEM: Other Events
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( General Instruction A.2. below):
see
 
 
 
 
Item 8.01 Other Events.
On January 31, 2008, SB2, Inc. filed a civil action against Alexion Pharmaceuticals, Inc. in the U.S. District Court for the Northern District of California. SB2, Inc. claims willful infringement by Alexion of SB2, Inc. patents. SB2, Inc. seeks, among other things, monetary damages and equitable relief.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ALEXION PHARMACEUTICALS, INC.
Date: February 4, 2008
By:  
/s/    Thomas I. H. Dubin                                
        Name: Thomas I. H. Dubin
        Title: Senior Vice President and
                  General Counsel


